New insights into the mechanism of action of acetaminophen:: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases

被引：152

作者：

Aronoff, DM

Oates, JA

Boutaud, O ^{[1
]}

机构：

[1] Vanderbilt Univ, Dept Pharmacol, Div Clin Pharmacol, Nashville, TN 37232 USA

[2] Vanderbilt Univ, Dept Internal Med, Div Clin Pharmacol, Nashville, TN 37232 USA

[3] Univ Michigan, Hlth Syst, Div Infect Dis, Dept Internal Med, Ann Arbor, MI 48109 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 01期

关键词：

D O I：

10.1016/j.clpt.2005.09.009

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：9 / 19

页数：11

共 66 条

[1]

[Anonymous], 1893, THER MONATSCH

[2] Inhibition of prostaglandin H2 synthases by salicylate is dependent on the oxidative state of the enzymes [J].

Aronoff, DM ;

Boutaud, O ;

Marnett, LJ ;

Oates, JA .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (02) :589-595

[3] Antipyretics: Mechanisms of action and clinical use in fever suppression [J].

Aronoff, DM ;

Neilson, EG .

AMERICAN JOURNAL OF MEDICINE, 2001, 111 (04) :304-315

[4] INHIBITION OF PROSTAGLANDIN SYNTHETASES DERIVED FROM NEURONAL AND GLIAL-CELLS AND RAT RENAL MEDULLA BY ORTHO-SUBSTITUTED, META-SUBSTITUTED AND PARA-SUBSTITUTED AMINOPHENOLIC COMPOUNDS [J].

BAUMANN, J ;

VANBRUCHHAUSEN, F ;

WURM, G .

PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1983, 10 (03) :319-329

[5] Mechanism of action of acetaminophen: Is there a cyclooxygenase 3? [J].

Botting, RM .

CLINICAL INFECTIOUS DISEASES, 2000, 31 :S202-S210

[6] Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases [J].

Boutaud, O ;

Aronoff, DM ;

Richardson, JH ;

Marnett, LJ ;

Oates, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :7130-7135

[7] Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway [J].

Boutaud, O ;

Brame, CJ ;

Salomon, RG ;

Roberts, LJ ;

Oates, JA .

BIOCHEMISTRY, 1999, 38 (29) :9389-9396

[8]

BOYD JA, 1981, J PHARMACOL EXP THER, V219, P659

[9]

BRODIE BB, 1949, J PHARMACOL EXP THER, V97, P58

[10] Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation [J].

Calzada, C ;

Vericel, E ;

Lagarde, M .

BIOCHEMICAL JOURNAL, 1997, 325 :495-500

← 1 2 3 4 5 6 7 →